The alternative expression levels of these genes in certain organs may act as an indicator of cancer development, including WFDC2 in ovarian cancer (28), ADAM29 and ADAM7 in melanoma (29) and Eppin in prostate cancer (30). This evidence concerns the gene WFDC2 and cancer.